ANIX
Anixa Biosciences Inc
Latest Form 4:Purchase$17KbyKUMAR AMIT (Chief Executive Officer) · filed Aug 3, 2026
Anixa Biosciences Inc (ANIX) has 14 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 3, 2026.
The most active filer is Chief Executive Officer KUMAR AMIT with 6 filings. Insiders have net bought $200K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Amit Kumar
- Employees:4
- HQ:San Jose, CA, US
- IPO:1983-10-07
Insider Buying
$230K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$118.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Purchase | 5,000 | $17K | Aug 3 | SEC ↗ | |
| Chief Executive Officer | Purchase | 8,188 | $28K | Jul 28 | SEC ↗ | |
| Chief Executive Officer | Purchase | 3,000 | $11K | Jul 27 | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $17K | Jul 21 | SEC ↗ | |
| Director | Purchase | 12,000 | $42K | Jul 20 | SEC ↗ | |
| Director | Purchase | 2,797 | $9K | Jul 16 | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $15K | Jul 13 | SEC ↗ | |
Titterton Lewis H jrFirst in 7 months | Director | Purchase | 2,836 | $7K | Jun 17 | SEC ↗ |
KUMAR AMITFirst filing | Chief Executive Officer | Purchase | 21,000 | $53K | Jun 16 | SEC ↗ |
Baskies Arnold MFirst filing | Director | Purchase | 10,000 | $30K | Jan 29 | SEC ↗ |
Related companies
Anixa Biosciences Inc is in the Healthcare sector.